About
Jingjing Chai is the co-founder and CEO of Foundry BioSciences, a Cambridge-based biotech company building AI-driven protein engineering tools for longevity and healthspan applications. Public company materials describe her as a Harvard alumna with more than a decade of experience in deeptech venture investing and technology transfer. She is also publicly associated with Taihill Venture, a Boston-based pre-seed deeptech fund, where sources describe her as a co-founding general partner or venture partner.
Areas of interest
longevityrejuvenation biotechprotein engineeringAI for sciencedeep techbiotechdrug discoverygene therapyagteche-commerce / last-mile logisticspre-seed venture